TXBiobytes from Texas Biomed
The latest news on biomedical research and discoveries from Texas Biomedical Research Institute
Listen to latest episode
Follow Our Podcast
Recent Episodes
TX Biobytes from Texas Biomed Episode 052— Understanding Variants
The United States reached another solemn milestone this week. 500 thousand people have lost their lives to COVID-19. This pandemic has drastically changed our world in ways no one could have imagined. And, every day it seems we are learning something new about the virus SARS-CoV-2. A critical component to all viruses is that they mutate. And, when they mutate they form a variant. When a virus constantly mutates, creating multiple variants, that can be a problem. There are now several mutations of SARS-CoV-2 circulating globally. In this podcast, we sit down with one of Texas Biomed's leading virologists, Dr. Jean Patterson, to get a basic understanding of a variant. We discuss how variants are formed, the difference between a variant and a new strain and what needs to be done to stay ahead of these evolutionary changes of a virus.
TX Biobytes from Texas Biomed Episode 051 — Second Annual Research Symposium 2020
Post Doctorate Fellow Marco Ferrari (L) presents his research poster during the Second Annual Research Symposium in February. Texas Biomed held its second annual research symposium in February. Known as Research Day, the symposium is an opportunity for scientists from around the Texas Biomed campus to present their research and give updates to faculty and staff. Topics ranging from HIV and Ebola to tuberculosis and pertussis and more were presented. In this episode of Biobytes, two scientists, Marco Ferrari and Kizil Yusoof, talk about their research and how it can improve lives. Motivational Speaker Shiloh Harris opened Research Day with his story about survival. Research Day was initiated to promote collaborative science among Texas Biomed researchers and other scientists.
TX Biobytes from Texas Biomed Episode 050 — New Coronavirus: Q&A
New Coronavirus - Credit: NIH NIAID As of today, February 26, 2020, the new coronavirus has infected more than 80,000 people worldwide, causing more than 2,200 deaths, and continues to be spreading. The CDC has warned that the virus is likely to spread in the United States. Scientists worldwide are frantically searching for therapies and vaccines to combat this threat and there appears to be some progress; however, any vaccine or therapeutic candidate will still have to undergo rigorous testing, including testing in animal models, which Texas Biomed is developing. Texas BioBytes sat down with three leading researchers to discuss the virus, scientific progress and what individuals can do to protect themselves. We spoke on February 17 with Dr. Larry Schlesinger, Professor, President and CEO of Texas Biomed; Dr. Jean Patterson, Professor, and this week's podcast also introduces Texas Biomed's newest faculty member and leading virologist on vaccine development Dr. Luis Martinez Sobrido, Professor. All facts and figures are from the time of the interview. Please join us for this roundtable discussion of one of the world's most current threats.
TX Biobytes from Texas Biomed Episode 049 — Texas Biomed: 2020 and Beyond
Texas Biomed President/CEO Larry Schlesinger, M.D. Texas Biomed launched a 10-year strategic plan in 2018 that aims to bring hundreds of jobs to San Antonio and double basic biomedical research funding at the Institute in order to ensure we fulfill our mission to protect you, your loved ones and our global community from the threat of infectious diseases. Recent headlines in the New York Times report "First Wuhan Coronavirus Patient Identified in the United States" and "W.H.O. Warns That Pipeline for New Antibiotics Is Running Dry." Daily news reports worldwide, like these, underscore not only the threat of new, emerging diseases but the resurgence of infectious diseases, like measles, as well as the global scourges of malaria, tuberculosis, HIV and other diseases that continue claiming the lives of millions worldwide. We sat down with President and CEO of Texas Biomed Dr. Larry Schlesinger to learn how we can get ahead of these threats and what he hopes Texas Biomed's role will be in the coming decade? Join us for our one-on-one conversation.
TX Biobytes from Texas Biomed Episode 048— Texas Biomed: The Next Generation
Texas Biomed trainees team up to produce a podcast about their experiences. Biomedical research trainees are an important part of the team of scientists at Texas Biomed. The next generation of innovative thinkers will grow out of those people working in labs all over the country while earning their higher degrees and conducting their post-doctoral work. In this podcast, you will hear from: Colwyn Headley, Ph.D. Candidate in Biomedical Science (Immunology) from Ohio State University. Kizil Yusoof, Masters student in Immunology and Infection at UT Health San Antonio Maritza Quintero, Ph.D. Candidate in Molecular Biophysics and Biochemistry at UT Health San Antonio Amanda Rae Mannino, MLS (ASCP), Ph.D. Candidate in the Cell Biology, Genetics and Molecular Medicine Discipline
POWERED BY BLUBRRY
